Tinea Pedis
📧 Sign up to get email alerts when something new happens for Tinea Pedis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-04-30FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) submitted by Legacy Pharma USA Inc. The action approves an upda…
-
FDA approval · 2018-04-18FDA Approved: ECONAZOLE NITRATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for econazole nitrate from Aurobindo Pharma Limited, enabling a generic topical antifungal product.
-
FDA approval · 2018-02-20FDA Approved: LUZU — Supplemental Application (Bausch Health US, LLC)
The FDA has approved a supplemental application for LUZU (luliconazole) submitted by Bausch Health US, LLC.
-
FDA approval · 2017-11-16FDA Approved: ATHLETES FOOT — Original Application (TOPCO ASSOCIATES LLC)
FDA approved a generic version of butenafine hydrochloride for the treatment of athlete's foot (tinea pedis) under Original Application by T…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Three-Arm Trial of Novel Treatment for Tinea Pedis [Phase 2]
Phase 2, three-arm trial of a novel treatment for tinea pedis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-08-25FDA Approved: UP AND UP MICONAZOLE — Supplemental Application (Target Corporation)
FDA approved a supplemental application for UP AND UP MICONAZOLE (miconazole nitrate) by Target Corporation, indicating a labeling or indica…
-
FDA approval · 2017-08-21FDA Approved: MICONAZOLE 3 — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for MICONAZOLE 3 (miconazole nitrate) by Rite Aid Corporation.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP) [Phase 1]
This clinical trial update reports completion of a Phase 1 study evaluating three regimens of W0027 for moccasin-type tinea pedis (athlete's…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: BE Study of Naftifine HCL [Phase 3]
A Phase 3 bioequivalence study of naftifine hydrochloride for tinea pedis has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis [Phase 1]
Phase 1 study evaluating the safety and efficacy of Naftifine hydrochloride 2% cream and Naftin 2% cream for tinea pedis has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis [Phase 1]
Phase 1 trial evaluating the safety and bioequivalence of a generic butenafine cream and Lotrimin Ultra compared with a vehicle in interdigi…
-
FDA approval · 2017-02-08FDA Approved: LUZU — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for LUZU (luliconazole) submitted by Bausch Health US, LLC.
-
CLINICAL_TRIALS withdrawal · 2017-02-01Clinical Trial Update: Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis [Phase 3]
A Phase 3 non-inferiority trial comparing dapaconazole 2% cream with ketoconazole 2% cream for treatment of tinea pedis has been withdrawn.
-
FDA approval · 2017-01-23FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Actavis Pharma's clotrimazole and betamethasone dipropionate topical product, indicating cha…
-
FDA approval · 2017-01-19FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) by Bayer Healthcare LLC.
-
FDA approval · 2016-12-20FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's Nystatin and Triamcinolone Acetonide as an Original Application (ANDA) for a topical antif…
-
FDA approval · 2016-12-13FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc. USA)
FDA approved Glenmark's supplemental application for Clotrimazole and Betamethasone Dipropionate. The approval updates the labeling for this…
-
FDA approval · 2016-09-08FDA Approved: NAFTIFINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' naftifine hydrochloride topical product under an Original Application.
-
FDA approval · 2016-08-25FDA Approved: CLOTRIMAZOLE — Supplemental Application (Foster and Thrive (Mckesson /STRATEGIC SOURCING SERVICES LLC))
The FDA approved a supplemental application for clotrimazole, reflecting a regulatory update to its approval.
-
FDA approval · 2016-08-01FDA Approved: ECOZA — Supplemental Application (Resilia Pharmaceuticals, Inc.)
FDA approves a supplemental application for ECOZA (econazole nitrate) from Resilia Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis [Phase 4]
Phase 4 pharmacokinetic study in pediatric patients with tinea pedis and tinea cruris has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis [Phase 2]
A Phase 2 trial comparing BL123 to ketoconazole for tinea pedis has completed; the snippet does not provide efficacy results.
-
FDA label_change · 2016-06-07FDA Approved: LUZU — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for LUZU (luliconazole) to update its labeling.
-
FDA approval · 2016-03-07FDA Approved: OXICONAZOLE NITRATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Oxiconazole Nitrate topical product from Sun Pharmaceutical Industries, Inc. This generic antifungal is indicated for common fu…
-
FDA approval · 2016-02-25FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Ciclopirox olamine to update labeling and support use for common superficial fungal skin infecti…